Lilly Announces Trial Results, Settlement

Posted: Updated:
Lilly says it will now launch a Phase III trial. Lilly says it will now launch a Phase III trial.
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says its cancer treatment Cyramza improved progression-free survival for patients with a certain type of bladder cancer in a Phase II study. Also today, the drugmaker announced it had reached a settlement agreement with France-based pharmaceutical company Sanofi over the rights to an insulin product.

Lilly says Cyramza met its primary endpoint in the study involving patients with metastatic urothelial carcinoma who failed previous therapy. The company says, based on the findings, it has launched a Phase III trial. Yale University Cancer Center Professor of Medicine Daniel Petrylak says he is encouraged by the findings because people with advanced urothelial carcinoma currently have limited treatment options.

The settlement with Sonafi involves the insulin product Basaglar. The agreement allows Lilly and partner Boehringer Ingelheim to launch the product in the United States in December. The settlement grants Lilly a royalty-bearing license to manufacture and sell Basaglar in the Kwikpen device. The Food and Drug Administration tentatively approved the product last year. Lilly says it will now request final approval.

  • Perspectives

    • States Can Foster Job Growth if Lifelong Learning is at Play

      The worlds of work and learning are merging in powerful ways, driven by the exponential growth in human knowledge. This means the abilities needed in the workplace go beyond simple “job skills” that can be learned quickly through a short-term training program. I was with Montana Gov. Steve Bullock when he released the newest National Governors Association report, “Governor’s Action Guide to Achieving Good Jobs for All Americans,” at the opening session...

    More

Events



  • Most Popular Stories

    • UPDATE: Nestl√© Details Fort Wayne Layoffs

      Virginia-based Nestlé USA says only 40 employees will be laid off at the company's Fort Wayne distribution center. A spokesperson for Nestlé tells Inside INdiana Business a WARN Notice filed with the state incorrectly stated the facility would close at the end of the year, affecting nearly 70 workers.

    • (photo courtesy The Times of Northwest Indiana)

      Hammond Pulls 135 Jobs from Illinois

      A Hammond factory recently vacated by Michigan-based Lear Corp. didn’t sit empty for very long. Midland Metal Products has taken over the former seat factory, having relocated from Chicago after 95 years. 

    • Northern Indiana Telemarketer Sentenced in Scheme

      A Merrillville telemarketer has been sentenced to over five years in prison for his role in a $10 million scheme to defraud mostly elderly victims in the United States. Carlin Woods, 35, pleaded guilty in 2017 to a count of conspiracy to commit wire fraud, one count of wire fraud and another conspiracy count to commit money laundering. 

    • 'Hottest Real Estate Markets' Include Indiana Locales

      Fort Wayne just opened its brand new riverfront Promenade Park to pomp and pageantry, hoping to make it a draw to Indiana’s second largest city. But now the Allen County community has something else to celebrate. The editors of Realtor.com declared Fort Wayne as the hottest real estate market in July for the entire country. 

    • (Image courtesy of Horseshoe Casino Hammond.)

      Indiana Casinos to Begin Sports Betting

      A pair of northwest Indiana casinos will soon add sports wagering to their offerings. Horseshoe Hammond Casino and Ameristar Casino East Chicago are both set to open sports betting areas at their respective casinos ahead of the kickoff to the 2019 NFL season.